Brown, L. M., Wilkins, S. G., Bansal, V. V., Su, D. G., Gomez‐Mayorga, J., Turaga, K. K., Gunderson, C. G., Lee, B., Nash, G. M., Hays, J. L., Raghav, K. P., Husain, A. L., Kluger, M. D., Zauderer, M. G., Kindler, H. L., & Alexander, H. R. (2025). Consensus guideline for the management of peritoneal mesothelioma. Cancer, 131(13). Portico. https://doi.org/10.1002/cncr.35868

Lieberman-Cribbin, W., & Taioli, E. (2023). Epidemiologic roadblocks in studying elongated mineral particles and mesothelioma risk. Environmental Research, 230, 115086. https://doi.org/10.1016/j.envres.2022.115086

Govindan, R., Aggarwal, C., Antonia, S. J., Davies, M., Dubinett, S. M., Ferris, A., Forde, P. M., Garon, E. B., Goldberg, S. B., Hassan, R., Hellmann, M. D., Hirsch, F. R., Johnson, M. L., Malik, S., Morgensztern, D., Neal, J. W., Patel, J. D., Rimm, D. L., Sagorsky, S., … Herbst, R. S. (2022). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. Journal for ImmunoTherapy of Cancer, 10(5), e003956. https://doi.org/10.1136/jitc-2021-003956